Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development?

This publication has 39 references indexed in Scilit:

• Poly(I:C) Treatment Leads to Interferon-Dependent Clearance of Hepatitis B Virus in a Hydrodynamic Injection Mouse Model
  Journal of Virology, 2014
• Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice
  Nucleic Acids Research, 2014
• Viral Quasispecies Evolution
  Microbiology and Molecular Biology Reviews, 2012
• The roles of TLRs, RLRs and NLRs in pathogen recognition
  International Immunology, 2009
• Nucleotide analogues with immunobiological properties: 9-[2-Hydroxy-3-(phosphonomethoxy)propyl]-adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives
  European Journal of Pharmacology, 2006
• Cleavage of the siRNA passenger strand during RISC assembly in human cells
  EMBO Reports, 2006
• Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine
  European Journal of Pharmacology, 2006
• Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7
  Proceedings of the National Academy of Sciences, 2003
• Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents
  Journal of Biological Chemistry, 2003
• Highly Immunostimulatory CpG-Free Oligodeoxynucleotides for Activation of Human Leukocytes
  Antisense and Nucleic Acid Drug Development, 2002